Merck & Co., Inc. Quarterly Other Liabilities, Noncurrent in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Merck & Co., Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2012 to Q3 2024.
  • Merck & Co., Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2024 was $7.54B, a 2.68% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $7.54B +$197M +2.68% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $7.33B +$64M +0.88% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $8.26B +$18M +0.22% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $8.79B +$469M +5.64% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $7.34B -$1.32B -15.2% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $7.27B -$1.69B -18.8% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $8.24B -$1.5B -15.4% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $8.32B -$1.11B -11.8% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $8.66B -$809M -8.54% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $8.95B -$921M -9.33% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $9.74B -$2.5B -20.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $9.43B -$2.87B -23.3% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $9.47B -$2.56B -21.3% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $9.87B -$2.57B -20.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $12.2B +$691M +5.98% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $12.3B +$336M +2.81% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $12B +$942M +8.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $12.4B +$1.16B +10.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $11.6B -$35M -0.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $12B -$71M -0.59% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $11.1B -$802M -6.75% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $11.3B -$745M -6.19% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $11.6B +$112M +0.98% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $12B +$924M +8.31% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $11.9B +$4.17B +54.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $12B +$3.96B +49.1% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $11.5B +$3.15B +37.8% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $11.1B +$2.6B +30.6% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $7.71B -$1.08B -12.3% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $8.07B -$310M -3.7% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $8.32B +$950M +12.9% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $8.51B +$1.17B +15.9% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $8.79B +$906M +11.5% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $8.38B +$465M +5.88% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $7.37B -$303M -3.95% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $7.35B -$468M -5.99% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $7.89B +$919M +13.2% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $7.91B -$262M -3.21% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $7.68B -$279M -3.51% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $7.81B -$323M -3.97% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $6.97B Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $8.18B Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $7.96B Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $8.14B -$2.19B -21.2% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $10.3B Dec 31, 2012 10-K 2014-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.